SlideShare a Scribd company logo
Case 
Study 
Client 
Client Need 
Solution Approach 
Results 
**Data has been sanitized and meant for Illustrative purposes only 
Finding Right partner for Indian market of their innovative micro-current based Ophthalmic Medical Device. 
The device prevents progression of dry ARMD (Age Related Macular Degeneration) and Retinitis Pigmentosa 
1 
Innovative Medical Device company from Minnesota 
A Distribution Partnership established with a Top Tier Pharma company specializing in Ophthalmic market 
Aagami first understood and captured the important details about the asset and the technology 
Identified Ophthalmic focused companies in India to invest in and distribute client product. 
Shortlisted 9 companies, both investors and distributors and sent them customized ‘Elevator Pitch’ (EP) 
After follow ups, CDAs and conference calls with interested parties Aagami organized a Road-Show to India with top management of client firm 
Aagami supported in structuring and negotiating the deal discussions. 
Successfully established the distribution relationship 
Lifesciences Catalyst

More Related Content

Similar to 140924 aagami-case study-sc-5-sf

Aagami Inc. Research Services Presentation
Aagami Inc. Research Services PresentationAagami Inc. Research Services Presentation
Aagami Inc. Research Services PresentationGodwyn Francis
 
Lif follow on support programme - chu duc hoang
Lif follow on support programme - chu duc hoang Lif follow on support programme - chu duc hoang
Lif follow on support programme - chu duc hoang
Hoang ChuDuc
 
Indian pharma outlook
Indian pharma outlookIndian pharma outlook
Indian pharma outlookjatin125
 
Rbsa india deals snapshot march 2016
Rbsa india deals snapshot march 2016Rbsa india deals snapshot march 2016
Rbsa india deals snapshot march 2016
RBSA Advisors
 
CRAMS Article_ Pharmabiz_CPHI_2015
CRAMS Article_ Pharmabiz_CPHI_2015CRAMS Article_ Pharmabiz_CPHI_2015
CRAMS Article_ Pharmabiz_CPHI_2015Ankit Gupta
 
slideshow-innvoexia.pdf
slideshow-innvoexia.pdfslideshow-innvoexia.pdf
slideshow-innvoexia.pdf
webtechleads123
 
Pharma and Digital: How New Approaches Enable the Path to Patient
Pharma and Digital: How New Approaches Enable the Path to PatientPharma and Digital: How New Approaches Enable the Path to Patient
Pharma and Digital: How New Approaches Enable the Path to Patient
Jacqueline Barendregt
 
Origiin Corporate Presentation 01
Origiin Corporate Presentation 01Origiin Corporate Presentation 01
Origiin Corporate Presentation 01
Anita Kalia
 
Business development of sunpharma presentation 3.pptx
Business development of sunpharma presentation 3.pptxBusiness development of sunpharma presentation 3.pptx
Business development of sunpharma presentation 3.pptx
dmrjput
 
JFN Capital & Co Patent/Technology Commercialization Approach
JFN Capital & Co Patent/Technology Commercialization ApproachJFN Capital & Co Patent/Technology Commercialization Approach
JFN Capital & Co Patent/Technology Commercialization Approach
John Fragkos
 
Win win strategies in indian market
Win win strategies in indian marketWin win strategies in indian market
Win win strategies in indian market
Lav Verma
 
Med strategist profile ver 6
Med strategist  profile ver 6Med strategist  profile ver 6
Med strategist profile ver 6
sriramsl
 
9th Annual Pricing And Reimbursement Conference
9th Annual Pricing And Reimbursement Conference9th Annual Pricing And Reimbursement Conference
9th Annual Pricing And Reimbursement Conferencejaayboy69
 
Pandesic case analysis
Pandesic case analysisPandesic case analysis
Pandesic case analysis
Aysha Rahman
 
Cii anti counterfeit_pkg_technologies_report
Cii anti counterfeit_pkg_technologies_reportCii anti counterfeit_pkg_technologies_report
Cii anti counterfeit_pkg_technologies_report
Bilcareltd
 
Cii anti counterfeit pkg technologies report by dr dhar
Cii anti counterfeit pkg technologies report by dr dharCii anti counterfeit pkg technologies report by dr dhar
Cii anti counterfeit pkg technologies report by dr dhar
Bilcareltd
 
Cii anti counterfeit pkg technologies report
Cii anti counterfeit pkg technologies reportCii anti counterfeit pkg technologies report
Cii anti counterfeit pkg technologies report
Bilcareltd
 
Cii anti counterfeit_pkg_technologies_report
Cii anti counterfeit_pkg_technologies_reportCii anti counterfeit_pkg_technologies_report
Cii anti counterfeit_pkg_technologies_reportBilcareltd
 
The Changing Pharma R&D Model, GDDIS Leaders Summit Ted Torphy CSO, Head, Ex...
The Changing Pharma R&D Model, GDDIS Leaders Summit  Ted Torphy CSO, Head, Ex...The Changing Pharma R&D Model, GDDIS Leaders Summit  Ted Torphy CSO, Head, Ex...
The Changing Pharma R&D Model, GDDIS Leaders Summit Ted Torphy CSO, Head, Ex...
GBX Summits
 
Integrated Branding Case Study A
Integrated Branding   Case Study AIntegrated Branding   Case Study A
Integrated Branding Case Study A
Gabe Mederos
 

Similar to 140924 aagami-case study-sc-5-sf (20)

Aagami Inc. Research Services Presentation
Aagami Inc. Research Services PresentationAagami Inc. Research Services Presentation
Aagami Inc. Research Services Presentation
 
Lif follow on support programme - chu duc hoang
Lif follow on support programme - chu duc hoang Lif follow on support programme - chu duc hoang
Lif follow on support programme - chu duc hoang
 
Indian pharma outlook
Indian pharma outlookIndian pharma outlook
Indian pharma outlook
 
Rbsa india deals snapshot march 2016
Rbsa india deals snapshot march 2016Rbsa india deals snapshot march 2016
Rbsa india deals snapshot march 2016
 
CRAMS Article_ Pharmabiz_CPHI_2015
CRAMS Article_ Pharmabiz_CPHI_2015CRAMS Article_ Pharmabiz_CPHI_2015
CRAMS Article_ Pharmabiz_CPHI_2015
 
slideshow-innvoexia.pdf
slideshow-innvoexia.pdfslideshow-innvoexia.pdf
slideshow-innvoexia.pdf
 
Pharma and Digital: How New Approaches Enable the Path to Patient
Pharma and Digital: How New Approaches Enable the Path to PatientPharma and Digital: How New Approaches Enable the Path to Patient
Pharma and Digital: How New Approaches Enable the Path to Patient
 
Origiin Corporate Presentation 01
Origiin Corporate Presentation 01Origiin Corporate Presentation 01
Origiin Corporate Presentation 01
 
Business development of sunpharma presentation 3.pptx
Business development of sunpharma presentation 3.pptxBusiness development of sunpharma presentation 3.pptx
Business development of sunpharma presentation 3.pptx
 
JFN Capital & Co Patent/Technology Commercialization Approach
JFN Capital & Co Patent/Technology Commercialization ApproachJFN Capital & Co Patent/Technology Commercialization Approach
JFN Capital & Co Patent/Technology Commercialization Approach
 
Win win strategies in indian market
Win win strategies in indian marketWin win strategies in indian market
Win win strategies in indian market
 
Med strategist profile ver 6
Med strategist  profile ver 6Med strategist  profile ver 6
Med strategist profile ver 6
 
9th Annual Pricing And Reimbursement Conference
9th Annual Pricing And Reimbursement Conference9th Annual Pricing And Reimbursement Conference
9th Annual Pricing And Reimbursement Conference
 
Pandesic case analysis
Pandesic case analysisPandesic case analysis
Pandesic case analysis
 
Cii anti counterfeit_pkg_technologies_report
Cii anti counterfeit_pkg_technologies_reportCii anti counterfeit_pkg_technologies_report
Cii anti counterfeit_pkg_technologies_report
 
Cii anti counterfeit pkg technologies report by dr dhar
Cii anti counterfeit pkg technologies report by dr dharCii anti counterfeit pkg technologies report by dr dhar
Cii anti counterfeit pkg technologies report by dr dhar
 
Cii anti counterfeit pkg technologies report
Cii anti counterfeit pkg technologies reportCii anti counterfeit pkg technologies report
Cii anti counterfeit pkg technologies report
 
Cii anti counterfeit_pkg_technologies_report
Cii anti counterfeit_pkg_technologies_reportCii anti counterfeit_pkg_technologies_report
Cii anti counterfeit_pkg_technologies_report
 
The Changing Pharma R&D Model, GDDIS Leaders Summit Ted Torphy CSO, Head, Ex...
The Changing Pharma R&D Model, GDDIS Leaders Summit  Ted Torphy CSO, Head, Ex...The Changing Pharma R&D Model, GDDIS Leaders Summit  Ted Torphy CSO, Head, Ex...
The Changing Pharma R&D Model, GDDIS Leaders Summit Ted Torphy CSO, Head, Ex...
 
Integrated Branding Case Study A
Integrated Branding   Case Study AIntegrated Branding   Case Study A
Integrated Branding Case Study A
 

140924 aagami-case study-sc-5-sf

  • 1. Case Study Client Client Need Solution Approach Results **Data has been sanitized and meant for Illustrative purposes only Finding Right partner for Indian market of their innovative micro-current based Ophthalmic Medical Device. The device prevents progression of dry ARMD (Age Related Macular Degeneration) and Retinitis Pigmentosa 1 Innovative Medical Device company from Minnesota A Distribution Partnership established with a Top Tier Pharma company specializing in Ophthalmic market Aagami first understood and captured the important details about the asset and the technology Identified Ophthalmic focused companies in India to invest in and distribute client product. Shortlisted 9 companies, both investors and distributors and sent them customized ‘Elevator Pitch’ (EP) After follow ups, CDAs and conference calls with interested parties Aagami organized a Road-Show to India with top management of client firm Aagami supported in structuring and negotiating the deal discussions. Successfully established the distribution relationship Lifesciences Catalyst